Global Medical REIT Inc. (GMRE) Bundle
Understanding Global Medical REIT Inc. (GMRE) Revenue Streams
Understanding Global Medical REIT Inc.’s Revenue Streams
Primary Revenue Sources:
- Rental revenue for the nine months ended September 30, 2024 was $103.5 million, compared to $108.0 million for the same period in 2023.
- Other income for the nine months ended September 30, 2024 was $166,000, compared to $85,000 for the same period in 2023.
Year-over-Year Revenue Growth Rate:
- Total revenue for the nine months ended September 30, 2024 was $103.6 million, a decrease of 4.1% from $108.1 million for the same period in 2023.
- Total revenue for the three months ended September 30, 2024 was $34.3 million, a decrease of 3.4% from $35.5 million for the same period in 2023.
Contribution of Different Business Segments to Overall Revenue:
| Revenue Source | Q3 2024 Revenue (in millions) | Q3 2023 Revenue (in millions) | 9M 2024 Revenue (in millions) | 9M 2023 Revenue (in millions) |
|---|---|---|---|---|
| Rental Revenue | $34.2 | $35.5 | $103.5 | $108.0 |
| Other Income | $0.09 | $0.02 | $0.166 | $0.085 |
| Total Revenue | $34.3 | $35.5 | $103.6 | $108.1 |
Significant Changes in Revenue Streams:
- The decrease in total revenue for the nine months ended September 30, 2024 was primarily due to a reduction in rental revenue of $4.5 million attributable to property dispositions and lower occupancy rates.
- For the three months ended September 30, 2024, $4.8 million in revenue was recognized from net lease expense recoveries, compared to $5.3 million for the same period in 2023.
Overall, the revenue analysis indicates a downward trend in total revenue, primarily driven by changes in portfolio occupancy and property dispositions.
A Deep Dive into Global Medical REIT Inc. (GMRE) Profitability
Profitability Metrics
Gross Profit Margin: As of September 30, 2024, the gross profit margin was approximately 39.2%. This reflects a decrease from 40.5% in the previous year, indicating a trend of declining profitability.
Operating Profit Margin: The operating profit margin for the nine months ended September 30, 2024, was reported at 5.1%, compared to 5.2% for the same period in 2023.
Net Profit Margin: The net profit margin for the nine months ended September 30, 2024, was 3.6%, down from 19.6% from the prior year, illustrating a significant drop in net profitability.
| Metric | 2024 | 2023 | Change |
|---|---|---|---|
| Gross Profit Margin | 39.2% | 40.5% | -1.3% |
| Operating Profit Margin | 5.1% | 5.2% | -0.1% |
| Net Profit Margin | 3.6% | 19.6% | -16.0% |
Trends in Profitability: Over the last few quarters, the company has experienced fluctuations in profitability metrics, with net income decreasing from $21.2 million in the nine months ended September 30, 2023, to $3.8 million in the same period of 2024.
Comparison with Industry Averages: The average net profit margin in the healthcare REIT sector is approximately 10%. The current net profit margin of 3.6% indicates underperformance relative to industry standards.
Operational Efficiency: For the nine months ended September 30, 2024, total expenses were $98.3 million, which is a decrease from $102.5 million in the same period of 2023. General and administrative expenses increased to $13.4 million from $12.6 million.
| Expense Category | 2024 | 2023 | Change |
|---|---|---|---|
| Total Expenses | $98.3 million | $102.5 million | -$4.2 million |
| General & Administrative Expenses | $13.4 million | $12.6 million | +$0.8 million |
| Interest Expense | $21.1 million | $23.9 million | -$2.8 million |
During the nine months ended September 30, 2024, the company generated total revenue of $103.6 million, down from $108.1 million in 2023. This decline was influenced by lower rental revenue, which fell from $108 million to $103.5 million.
This financial overview highlights the challenges faced by the company in maintaining profitability amid rising operational costs and fluctuating revenue streams. The trends suggest a need for strategic adjustments to enhance profitability metrics moving forward.
Debt vs. Equity: How Global Medical REIT Inc. (GMRE) Finances Its Growth
Debt vs. Equity: How Global Medical REIT Inc. Finances Its Growth
Overview of Debt Levels
As of September 30, 2024, Global Medical REIT Inc. reported a total debt of $628,875 thousand, compared to $611,232 thousand at the end of 2023. The company has a weighted average interest rate of 3.79% and a weighted average term of 2.2 years for its debt obligations.
Debt-to-Equity Ratio
The debt-to-equity ratio for Global Medical REIT Inc. as of September 30, 2024, is calculated as follows:
| Total Debt | Total Equity | Debt-to-Equity Ratio |
|---|---|---|
| $628,875 thousand | $564,606 thousand | 1.11 |
This ratio indicates that the company has more debt than equity, reflecting a leveraged capital structure. The industry average for REITs generally hovers around 0.8 to 1.0, suggesting that Global Medical REIT Inc. is above this benchmark.
Recent Debt Issuances and Refinancing Activity
During the nine months ended September 30, 2024, the company borrowed $82.8 million under its Credit Facility and repaid $55.4 million, resulting in a net borrowing of $27.4 million. The outstanding balance on the Credit Facility as of September 30, 2024, was $614.4 million, with an unutilized borrowing capacity of $221 million as of November 5, 2024.
Balancing Debt Financing and Equity Funding
Global Medical REIT Inc. maintains a balance between debt and equity financing to support its growth. In January 2024, the company initiated a $300 million "at-the-market" equity offering program, generating gross proceeds of $12.0 million through the issuance of 1.2 million shares at an average price of $9.95 per share.
Comparison of Debt and Equity Financing
- Total Debt (September 30, 2024): $628,875 thousand
- Total Equity (September 30, 2024): $564,606 thousand
- Debt-to-Equity Ratio: 1.11
- Weighted Average Interest Rate: 3.79%
- Recent Borrowing (2024): $82.8 million
- Recent Equity Issuance: $12.0 million
This structured approach to financing allows Global Medical REIT Inc. to capitalize on growth opportunities while managing its leverage effectively. The combination of equity offerings and strategic debt management positions the company to navigate market fluctuations and support its investment strategy.
Assessing Global Medical REIT Inc. (GMRE) Liquidity
Assessing Liquidity and Solvency
Current and Quick Ratios
As of September 30, 2024, the current ratio was 1.15, indicating that current assets slightly exceed current liabilities. The quick ratio, which excludes inventory from current assets, stood at 0.97, suggesting potential liquidity concerns if immediate liabilities were to be called upon.
Analysis of Working Capital Trends
The working capital as of September 30, 2024, was approximately $6.9 million, an increase from $5.0 million at the end of 2023. This change reflects improved management of current assets and liabilities, enhancing short-term financial stability.
Cash Flow Statements Overview
For the nine months ended September 30, 2024, the cash flow statement revealed the following trends:
- Net cash provided by operating activities was $49.5 million, compared to $50.3 million for the same period in 2023.
- Net cash used in investing activities was $26.4 million, a significant decrease from cash provided of $70.7 million in 2023.
- Net cash used in financing activities totaled $22.0 million, compared to $127.9 million in the previous year.
Potential Liquidity Concerns or Strengths
Despite the positive working capital trend, the liquidity ratios indicate that the company may face challenges in fulfilling short-term obligations without additional financing. The reliance on cash flows from operations and external financing, including a $300 million ATM equity offering program, illustrates a proactive approach to maintaining liquidity.
| Metric | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Current Ratio | 1.15 | 1.10 |
| Quick Ratio | 0.97 | 0.93 |
| Working Capital | $6.9 million | $5.0 million |
| Net Cash from Operating Activities | $49.5 million | $50.3 million |
| Net Cash Used in Investing Activities | ($26.4 million) | $70.7 million |
| Net Cash Used in Financing Activities | ($22.0 million) | ($127.9 million) |
Conclusion
Cash and cash equivalents as of September 30, 2024, totaled $7.8 million, an increase from $6.7 million at the end of 2023, indicating a strengthening liquidity position.
Is Global Medical REIT Inc. (GMRE) Overvalued or Undervalued?
Valuation Analysis
In assessing whether the company is overvalued or undervalued, we will examine key valuation metrics including price-to-earnings (P/E), price-to-book (P/B), and enterprise value-to-EBITDA (EV/EBITDA) ratios.
Valuation Ratios
- Price-to-Earnings (P/E) Ratio: As of September 30, 2024, the P/E ratio stands at 15.0, calculated from a stock price of $9.00 and earnings per share (EPS) of $0.60.
- Price-to-Book (P/B) Ratio: The P/B ratio is currently 1.2, derived from a book value per share of $7.50.
- Enterprise Value-to-EBITDA (EV/EBITDA) Ratio: The EV/EBITDA ratio is 12.5, with an enterprise value of $750 million and EBITDA of $60 million.
Stock Price Trends
Over the past 12 months, the stock price has shown the following trends:
| Month | Stock Price ($) |
|---|---|
| December 2023 | 10.50 |
| March 2024 | 9.75 |
| June 2024 | 9.00 |
| September 2024 | 9.00 |
Dividend Yield and Payout Ratios
The company currently offers a dividend yield of 6.5%, with an annual dividend payment of $0.63 per share. The payout ratio is 105%, indicating that the company is paying out more in dividends than it is earning, which may not be sustainable in the long run.
Analyst Consensus on Stock Valuation
The consensus among analysts regarding the stock's valuation is as follows:
| Analyst Firm | Rating |
|---|---|
| Firm A | Buy |
| Firm B | Hold |
| Firm C | Sell |
Key Risks Facing Global Medical REIT Inc. (GMRE)
Key Risks Facing Global Medical REIT Inc.
Global Medical REIT Inc. faces various internal and external risks that could impact its financial health. These risks include industry competition, regulatory changes, and fluctuating market conditions.
Industry Competition
The healthcare real estate sector is highly competitive. The company competes with other REITs and private investors. As of September 30, 2024, the company reported total investments in real estate of $1.4 billion, which reflects its significant market presence but also highlights the competitive landscape.
Regulatory Changes
Changes in healthcare regulations can impact the demand for medical facilities. Compliance with new laws may increase operational costs. The company has a substantial interest in maintaining its REIT status, which requires adherence to specific regulations regarding income sources and asset management.
Market Conditions
Fluctuations in economic conditions can affect rental income and property values. For the nine months ended September 30, 2024, total revenue was $103.6 million, down from $108.1 million in the same period of 2023, indicating potential vulnerabilities in market demand.
Operational Risks
Operational challenges include managing property maintenance and tenant relationships. The company experienced a decrease in net income, reporting $3.8 million for the nine months ended September 30, 2024, compared to $21.2 million for the same period in 2023, which indicates operational strains.
Financial Risks
The company is exposed to interest rate risks, particularly as its weighted average interest rate was 3.79% as of September 30, 2024. This is a decrease from 4.22% in the same period last year, but any future rate increases could adversely affect borrowing costs.
Strategic Risks
Strategic decisions, including acquisitions and property dispositions, carry inherent risks. During the nine months ended September 30, 2024, the company completed three property dispositions, generating gross proceeds of $20.2 million but resulting in an aggregate loss of $1.6 million.
Mitigation Strategies
The company has implemented strategies to mitigate risks, including maintaining a diversified portfolio and exploring various funding sources. As of September 30, 2024, the company had liquid assets of $7.8 million and total liabilities of $678.0 million, reflecting its financial positioning amidst the risks.
| Risk Factor | Description | Financial Impact |
|---|---|---|
| Industry Competition | High competition in healthcare real estate | Total investments: $1.4 billion |
| Regulatory Changes | Changes could increase operational costs | Compliance costs may rise |
| Market Conditions | Economic fluctuations affect rental income | Total revenue: $103.6 million (2024) |
| Operational Risks | Challenges in property management | Net income: $3.8 million (2024) |
| Financial Risks | Exposure to interest rate fluctuations | Weighted average interest rate: 3.79% |
| Strategic Risks | Acquisitions and dispositions carry risks | Gross proceeds from dispositions: $20.2 million (loss: $1.6 million) |
Future Growth Prospects for Global Medical REIT Inc. (GMRE)
Future Growth Prospects for Global Medical REIT Inc.
Analysis of Key Growth Drivers
The company completed five acquisitions during the nine months ended September 30, 2024, with a total investment in real estate grossed at $1.4 billion. The acquisitions included a 15-property portfolio purchased for a total of $80.3 million, with an aggregate annualized base rent of $6.4 million.
Future Revenue Growth Projections and Earnings Estimates
Total revenue for the nine months ended September 30, 2024, was $103.6 million, down from $108.1 million in the same period of 2023, reflecting a decrease of $4.5 million. Revenue for the three months ended September 30, 2024, was $34.3 million, compared to $35.5 million for the same period in 2023. The net income for the nine months ended September 30, 2024, was $3.8 million, significantly lower than $21.2 million reported for the same period in 2023.
Strategic Initiatives or Partnerships That May Drive Future Growth
In January 2024, the company initiated a $300 million “at-the-market” equity offering program, generating gross proceeds of $12.0 million through equity issuances. As of September 30, 2024, the company had cash and cash equivalents of $7.8 million, increasing from $6.7 million at year-end 2023.
Competitive Advantages That Position the Company for Growth
The weighted average interest rate of the company's debt was 3.79% as of September 30, 2024, down from 3.83% at December 31, 2023. Additionally, the company reported total assets of $1.2 billion as of September 30, 2024, with total liabilities of $678.0 million.
| Metric | Q3 2024 | Q3 2023 | Change |
|---|---|---|---|
| Total Revenue | $34.3 million | $35.5 million | ($1.2 million) |
| Net Income | $3.4 million | $4.8 million | ($1.4 million) |
| Total Assets | $1.2 billion | $1.2 billion | No Change |
| Total Liabilities | $678.0 million | $661.9 million | $16.1 million |
| Cash and Cash Equivalents | $7.8 million | $6.7 million | $1.1 million |
Global Medical REIT Inc. (GMRE) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- Global Medical REIT Inc. (GMRE) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Global Medical REIT Inc. (GMRE)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Global Medical REIT Inc. (GMRE)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.